Laddar...
Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms
In myeloproliferative neoplasms (MPNs) the incidence of venous thromboembolism (VTE) is 0.6–1.0 per 100 pt-years, and the rate of recurrence after VTE is 6.0–6.5 per 100 pt-yrs. Vitamin K-antagonists (VKA) reduces the risk of recurrence after VTE at usual sites (i.e., deep venous thrombosis (DVT) of...
Sparad:
| I publikationen: | Blood Cancer J |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group UK
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6018810/ https://ncbi.nlm.nih.gov/pubmed/29946112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-018-0101-8 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|